Global dealmaking is off to its fastest start since 2007, with the value of
mergers and acquisitions struck in the first three months up 21 per cent on the same period a year ago, to $811bn.
Healthcare groups led the way, with a further three deals unveiled yesterday. UnitedHealth Group said it was acquiring prescription management company Catamaran in a $12.8bn all-cash deal; Horizon Pharma, a US-listed drugmaker, reached a $1.1bn deal for Hyperion Therapeutics; and Israel’s largest drugmaker Teva Pharmaceuticals bought Auspex for $3.2bn.
您已阅读40%（543字），剩余60%（818字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。